e-learning
resources
Stockholm 2007
Monday 17.09.2007
Cystic fibrosis lung disease: from diagnosis to end-stage
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Lung clearance index improves with treatment of an exacerbation in cystic fibrosis
A. Horsley, C. Saunders, R. Gray, K. Macleod, M. Dewar, N. Voase, A. Greening, S. Cunningham, J. Davies, E. Alton, J. A. Innes (Edinburgh, London, United Kingdom)
Source:
Annual Congress 2007 - Cystic fibrosis lung disease: from diagnosis to end-stage
Session:
Cystic fibrosis lung disease: from diagnosis to end-stage
Session type:
Oral Presentation
Number:
2664
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Horsley, C. Saunders, R. Gray, K. Macleod, M. Dewar, N. Voase, A. Greening, S. Cunningham, J. Davies, E. Alton, J. A. Innes (Edinburgh, London, United Kingdom). Lung clearance index improves with treatment of an exacerbation in cystic fibrosis. Eur Respir J 2007; 30: Suppl. 51, 2664
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Optimizing invasive ventilation for SMA type 1 children who are receiving the gene therapy
Cystic fibrosis and intestinal organoids
Clinics of Cystic Fibrosis Patients with Unusual Bacteria Isolated fromRespiratory Cultures
Related content which might interest you:
Lung clearance index in cystic fibrosis subjects treated for pulmonary exacerbations
Source: Eur Respir J 2015; 46: 1055-1064
Year: 2015
The lung clearance index correlates with markers of pulmonary deterioration in patients with cystic fibrosis
Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Year: 2013
Long-term course of lung clearance index among patients with cystic fibrosis
Source: Virtual Congress 2020 – Respiratory physiology and sleep: new approaches to diagnosis and treatment
Year: 2020
Symptom duration and the lung clearance index in children with cystic fibrosis and pulmonary exacerbations
Source: International Congress 2019 – Physiology of cystic fibrosis
Year: 2019
Lung clearance index and lung ultrasound in cystic fibrosis children
Source: International Congress 2018 – Cystic fibrosis: diagnosis and monitoring
Year: 2018
Association of lung clearance index with survival in individuals with cystic fibrosis
Source: Eur Respir J, 59 (3) 2100432; 10.1183/13993003.00432-2021
Year: 2022
Lung clearance index during pulmonary exacerbation in school-age children with cystic fibrosis
Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Year: 2013
Lung clearance index predicts pulmonary exacerbations in cystic fibrosis
Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment
Year: 2014
Lung clearance index in adult cystic fibrosis patients: the role of convection-dependent lung units
Source: Eur Respir J 2013; 42: 380-388
Year: 2013
Improving airway clearance in cystic fibrosis lung disease
Source: Eur Respir Monogr 2014; 64: 169-187
Year: 2014
Increased systemic inflammation in cystic fibrosis (CF) is associated with deterioration in lung clearance index (LCI)
Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology
Year: 2014
Airway infection, systemic inflammation and lung clearance index in children and adults with cystic fibrosis
Source: Eur Respir J, 51 (2) 1701704; 10.1183/13993003.01704-2017
Year: 2018
Cystic fibrosis lung disease assessed by lung clearance index
Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Year: 2013
Evolution of lung clearance index during the first year of life in cystic fibrosis
Source: Virtual Congress 2021 – Monitoring of lung disease and CFTR function in children with cystic fibrosis
Year: 2021
Lung clearance index in bronchiectasis
Source: International Congress 2017 – Non-CF bronchiectasis in children
Year: 2017
Longitudinal course of clinically measured lung clearance index in children with cystic fibrosis
Source: Virtual Congress 2020 – New frontiers in cystic fibrosis imaging and lung physiology
Year: 2020
Early detection of pulmonary exacerbations in children with cystic fibrosis by electronic home monitoring of symptoms and lung function
Source: International Congress 2016 – Cystic fibrosis: monitoring and management
Year: 2016
Regular exercise improves airway inflammation in cystic fibrosis patients
Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Year: 2013
Tracking pulmonary exacerbations in preschool children using the lung clearance index
Source: International Congress 2016 – Cystic fibrosis: monitoring and management
Year: 2016
Biomarkers of early relapse of pulmonary exacerbation in cystic fibrosis adult patients
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept